CDER Drug Links

• Guidance

• Approved Drugs

• Approval Process

• Electronic Submissions

• Firm Registration Status

• Postmarketing Study Commitments

• Good Manufacturing Practice Regulations

• National Drug Code Directory

• MedWatch: Adverse Event Reporting

• Forms

• Presentations

• Meetings/Workshops

• Generic Drugs

• Pharmacology//Toxicology

• Small Business

• En Español

• Contact the Center for Drug Evaluation and Research

• CDER Presentations

• CDER Meetings

Medical Device Links

• Guidance

• Industry Assistance

• Software Validation

• Design Control Guidance

• Good Manufacturing Practice/Quality Systems

• In Vitro Diagnostic Device Evaluation and Safety

• Device Advice

• Device Listing

• Establishment Registration

• Workshops and Conferences

• Advisory Meetings

• Medical Device Reporting

• Medical Device Databases

• Forms

• Contact the Center for Devices and Radiological Health

• CDRH Workshops

• CDRH Advisory Committees/Panel Meetings

Industry Assistance

• Combination Products

• Device Advice

• Electronic Submissions / eCopies

• Guidance documents

• Importing in the U.S.

• Industry Support

• International issues

• Medical device reporting (MDR)

• Getting market clearance / approval

• Ombudsman

• Standards

• STED Pilot Program

• Third party review

• Third party inspection

About CDRH

• Advisory committees

• Medical Device Fellowship Program

• Job information

• Outside Leveraging

• Meetings and presentations

• Organizational information

• Strategic planning

• Office of Science and Engineering Laboratories

Device Program Areas

• Clinical Laboratory
  Improvement Amendments

• Compliance activities

• Device evaluation information

• FDA Modernization Act

• Good manufacturing practice

• Human Factors

• In Vitro Diagnostic Devices

• Medical Device User Fee
  and Modernization Act of 2002

• Postmarket initiative

• Postmarket surveillance

• Registration and listing

• Reuse of single-use devices

CFR Rule Changes
this week - 558

Friday, Nov. 23, 2007

RULES
Animal drugs, feeds, and related products:
     Ractopamine,
     65666–65667 [E7–22882]   [TEXT]  [PDF]

NOTICES
Memorandums of understanding:
     FDA and Duke University; human subjects protection; clinical trials,
     65745–65749 [07–5793]   [TEXT]  [PDF]

Reports and guidance documents; availability, etc.:
     Radiofrequency identification feasibility studies; compliance policy guide,

     65750 [E7–22818]   [TEXT]  [PDF]
     Smallpox (variola) infection: developing drugs for treatment or prevention; industry guidance,
     65750–65751 [E7–22884]   [TEXT]  [PDF]
     Stability testing of new veterinary drug substances and medicinal products; industry guidance,
     65751–65752 [E7–22900]   [TEXT]  [PDF]
     Veterinary Medicinal Products, International Cooperation on Harmonisation of Technical requirements for Registration—
     65752–65753 [E7–22901]   [TEXT]  [PDF]
     65753–65754 [E7–22902]   [TEXT]  [PDF]
    

Thursday, Nov. 22, 2007

NONE

 

Wednesday, Nov. 21, 2007

NONE

Tuesday, Nov. 20, 2007

NOTICES
Agency information collection activities; proposals, submissions, and approvals,
65341–65342 [E7–22649]   [TEXT]  [PDF]
 

Monday, Nov. 19, 2007

NOTICES

Agency information collection activities; proposals, submissions, and approvals,
65033–65034 [E7–22480]   [TEXT]  [PDF]
65034–65036 [E7–22489]   [TEXT]  [PDF]
65036–65037 [E7–22492]   [TEXT]  [PDF]
65037–65038 [E7–22495]   [TEXT]  [PDF]
65038–65039 [E7–22586]   [TEXT]  [PDF]
65039–65041 [E7–22587]   [TEXT]  [PDF]
65041–65042 [E7–22588]   [TEXT]  [PDF]

Food additive petitions:
     ARCH Chemicals, Inc.; withdrawn,
     65042 [E7–22536]   [TEXT]  [PDF]

Memorandums of understanding:
     Association of American Feed Control Officials; feed ingredients definition, disputes resolution, etc.; responsibilities clarification,
     65042–65046 [07–5748]   [TEXT]  [PDF]

Reports and guidance documents; availability, etc.:
     Voting Procedures for Advisory Committee Meetings,
     65046–65047 [07–5751]   [TEXT]  [PDF]